Amgen plows ahead with costly, highly toxic cancer drug dosing despite FDA challenge
Amgen headquarters in Thousand Oaks, California. Adobe Stock When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the …
Amgen plows ahead with costly, highly toxic cancer drug dosing despite FDA challenge Read More